MRI acquisition automation moves from “pilot” to provider-backed platform
Date: January 16, 2026 | Topic: Medical Imaging & MRI | Company: Vista AI Vista AI closed a $29.5M Series B with a notable twist: multiple strategic health systems participated—an unusually strong market signal that MRI automation is becoming operational infrastructure, not just “AI at the reading workstation.” Vista AI is leveraging an FDA-cleared platform […]
Aidoc: FDA “multi-triage” clearance marks the platform bundling phase
Date: January 26, 2026 | Sector Lens: Medical Imaging + AI | Radiology workflow + acute triage (CADt)| Company: Aidoc Aidoc received FDA 510(k) clearance for BriefCase‑Triage: CARE Multi‑triage CT Body, enabling a single abdominal CT triage workflow spanning 14 acute findings (11 newly cleared + 3 previously cleared). This is a clean “market signal” […]
Markintel Pulse Insights — Radiology AI Shifts from Apps to Platforms (Jan 23, 2026)
ONE BIG THING Imaging AI is splitting into two winning lanes—multi‑indication “operational triage” that earns enterprise budgets and clearances, and a GenAI “explainability layer” forced by transparency rules—while payer scrutiny tightens the bar for anything that can’t prove measurable outcomes. KEY TAKEAWAYS MARKETSTRAT POV (ACTIONABLE STRATEGY) INNOVATION HOOK The “Explainability Layer” Becomes the New ROI […]
Markintel Pulse Insights — MRI Automation Becomes the Capacity Lever – JAN 16, 2026
ONE BIG THING Imaging AI’s “center of value” moved upstream this week—away from interpretation-only tools and toward acquisition automation + open foundation models that directly translate into throughput, staffing leverage, and faster access. KEY TAKEAWAYS MARKETSTRAT POV (ACTIONABLE STRATEGY) INNOVATION HOOK MRI demand continues rising while technologist scarcity and protocol complexity cap throughput. This week’s […]
MARKINTEL PULSE – WEEKLY MEDTECH, IMAGING & DIGITAL HEALTH INSIGHTS – JAN 9, 2026
ONE BIG THING FDA’s Jan‑6 guidance pair (CDS + General Wellness) materially widens the “non‑device” lane for AI in care delivery—shifting near‑term advantage from model performance to defensible deployment economics (workflow fit, evidence, liability controls, and integration). KEY TAKEAWAYS MARKETSTRAT POV (ACTIONABLE STRATEGY) INNOVATION HOOK Bedside imaging is becoming an economic weapon For imaging providers, […]
The Battle for the Cath Lab Cockpit: Why Philips’ Acquisition of SpectraWAVE Resets the Interventional Stack
Date: December 23, 2025 | Topic: Medical Imaging & Interventional Strategy | Company: Royal Philips (NYSE: PHG) Philips’ acquisition of SpectraWAVE is not a product expansion—it is a platform defense designed to close the company’s only major strategic gap against Abbott and Boston Scientific: the integrated high-resolution imaging stack. Executive Brief: The “So What” Philips’ […]
MARKINTEL PULSE – WEEKLY MEDTECH, IMAGING & DIGITAL HEALTH INSIGHTS – DEC 19, 2025
ONE BIG THING Imaging AI is shifting from “algorithm shelfware” to system-level workflow infrastructure — and this week’s mix of foundation-model progress, enterprise neuro workflow partnerships, and cath-lab AI M&A signals a platform land-grab that will redefine how imaging revenue is captured (through throughput, pathways, and coordination), not just per-study detection accuracy. KEY TAKEAWAYS MARKETSTRAT […]
MARKINTEL PULSE – WEEKLY MEDTECH, IMAGING & DIGITAL HEALTH INSIGHTS – DEC 12, 2025
ONE BIG THING One Big Thing: RSNA 2025 confirmed that “AI in imaging” is no longer a feature race—it’s an operating-layer land grab where cloud enterprise imaging, workflow copilots, and hardware-native AI converge into platform economics (recurring revenue, attach, and lock-in) with early, measurable productivity proof-points. Market Lens baseline (house view): AI-in-Imaging TAM = $28.4B […]
Marketstrat Releases ‘World Market for Oncology Imaging AI 2023–2032’ Horizon Report
Marketstrat Releases ‘World Market for Oncology Imaging AI 2023–2032,’ Mapping a US$604.7M Market to US$7.74B by 2032 New Markintel™ Horizon report explains how AI is becoming workflow‑critical infrastructure across oncology imaging pathways. SACRAMENTO, CA, UNITED STATES – Dec 10, 2025 – Marketstrat today announced the release of its latest Markintel™ Horizon report, World Market for […]
RSNA 2025 Day 3 Signals – Risk Biomarkers, AI Governance and AI‑native Imaging Workflows
Key Takeaways – RSNA 2025 Day 3 Major Vendor Bets Innovation Hook – From Pixels to Prevention Programs RSNA 2025’s Day 3 signal is not another gadget or one more AI algorithm. It’s the convergence of: For Marketstrat’s clients, the strategic question coming out of Day 3 is: How quickly can you move from “demo‑ready […]
